ANGLIA RUSKIN UNIVERSITY HIGHER EDUCATION CORPORATION
发明人:
Selim CELLEK,Marcus ILG,David RALPH,Asif MUNEER,Marta MATEUS,William STEBBEDS
申请号：
US16576653
公开号：
US20200108069A1
申请日:
2019.09.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention relates to the treatment of fibrotic conditions, such as Peyronie's disease, by administering a phosphodiesterase type 5 (PDE5) inhibitor, such as vardenafil, and a selective oestrogen receptor modulator (SERM), such as tamoxifen, to an individual in need thereof.
